These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 33550162)

  • 21. Human papilloma virus DNA-biomarker analysis for cervical cancer: Signal enhancement by gold nanoparticle-coupled tetravalent streptavidin-biotin strategy.
    Lv Q; Wang Y; Su C; Lakshmipriya T; Gopinath SCB; Pandian K; Perumal V; Liu Y
    Int J Biol Macromol; 2019 Aug; 134():354-360. PubMed ID: 31078598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
    Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
    Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent.
    Wang J; Liu J; Song G; Cao Z; Pan J; Li X; Gao Y; Qi J; Chen Z; Fan G; Bai X; Zhang R; Wang R; Duan Q; Li L; Shen X; Ma X
    Arch Virol; 2020 Oct; 165(10):2241-2247. PubMed ID: 32681408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid biopsy of HPV DNA in cervical cancer.
    Cheung TH; Yim SF; Yu MY; Worley MJ; Fiascone SJ; Chiu RWK; Lo KWK; Siu NSS; Wong MCS; Yeung ACM; Wong RRY; Chen ZG; Elias KM; Chung TKH; Berkowitz RS; Wong YF; Chan PKS
    J Clin Virol; 2019 May; 114():32-36. PubMed ID: 30913520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An electrochemiluminescent DNA sensor based on nano-gold enhancement and ferrocene quenching.
    Yao W; Wang L; Wang H; Zhang X; Li L; Zhang N; Pan L; Xing N
    Biosens Bioelectron; 2013 Feb; 40(1):356-61. PubMed ID: 22960011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
    Shen Y; Gong J; He Y; Cheng G; Okunieff P; Li X
    J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
    Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA.
    Daskou M; Tsakogiannis D; Dimitriou TG; Amoutzias GD; Mossialos D; Kottaridi C; Gartzonika C; Markoulatos P
    J Virol Methods; 2019 Aug; 270():87-94. PubMed ID: 31042552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV detection methods and genotyping techniques in screening for cervical cancer.
    Eide ML; Debaque H
    Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection.
    Fontecha N; Nieto MC; Andía D; Cisterna R; Basaras M
    Virol J; 2017 Mar; 14(1):50. PubMed ID: 28279212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus.
    Barcellos RB; Almeida SE; Sperhacke RD; Verza M; Rosso F; Medeiros RM; Perizzolo PF; Cortez-Herrera E; Rossetti ML
    J Virol Methods; 2011 Oct; 177(1):38-43. PubMed ID: 21807028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
    Polman NJ; Oštrbenk A; Xu L; Snijders PJF; Meijer CJLM; Poljak M; Heideman DAM; Arbyn M
    J Clin Microbiol; 2017 Dec; 55(12):3544-3551. PubMed ID: 29021152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
    Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18.
    Layman H; Rickert KW; Wilson S; Aksyuk AA; Dunty JM; Natrakul D; Swaminathan N; DelNagro CJ
    PLoS One; 2020; 15(3):e0229672. PubMed ID: 32214362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.